- Home
- ACHV vs MPV Comparison
ACHV vs MPV Comparison
Compare ACHV & MPV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACHV
- MPV
- Stock Information
- Founded
- ACHV N/A
- MPV 1988
- Country
- ACHV United States
- MPV United States
- Employees
- ACHV N/A
- MPV N/A
- Industry
- ACHV Biotechnology: In Vitro & In Vivo Diagnostic Substances
- MPV Finance Companies
- Sector
- ACHV Health Care
- MPV Finance
- Exchange
- ACHV Nasdaq
- MPV Nasdaq
- Market Cap
- ACHV 167.6M
- MPV 201.1M
- IPO Year
- ACHV N/A
- MPV N/A
- Fundamental
- Price
- ACHV $4.81
- MPV $19.40
- Analyst Decision
- ACHV Strong Buy
- MPV
- Analyst Count
- ACHV 1
- MPV 0
- Target Price
- ACHV $12.00
- MPV N/A
- AVG Volume (30 Days)
- ACHV 2.4M
- MPV 25.2K
- Earning Date
- ACHV 11-06-2025
- MPV 01-01-0001
- Dividend Yield
- ACHV N/A
- MPV 8.71%
- EPS Growth
- ACHV N/A
- MPV N/A
- EPS
- ACHV N/A
- MPV 1.71
- Revenue
- ACHV N/A
- MPV N/A
- Revenue This Year
- ACHV N/A
- MPV N/A
- Revenue Next Year
- ACHV N/A
- MPV N/A
- P/E Ratio
- ACHV N/A
- MPV $9.35
- Revenue Growth
- ACHV N/A
- MPV N/A
- 52 Week Low
- ACHV $1.84
- MPV $11.18
- 52 Week High
- ACHV $5.78
- MPV $16.42
- Technical
- Relative Strength Index (RSI)
- ACHV 61.90
- MPV 44.38
- Support Level
- ACHV $4.65
- MPV $19.03
- Resistance Level
- ACHV $5.42
- MPV $20.13
- Average True Range (ATR)
- ACHV 0.44
- MPV 0.55
- MACD
- ACHV 0.02
- MPV -0.02
- Stochastic Oscillator
- ACHV 64.34
- MPV 33.88
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.
About MPV Barings Participation Investors
Barings Participation Investors is a diversified closed-ended management investment company. The Trust's investment objective is to maintain a portfolio of securities providing a current yield and an opportunity for capital gains. Its principal investments are privately placed, below-investment grade, long-term debt obligations including bank loans and mezzanine debt instruments. The company invests in various sectors such as aerospace and defense; automotive; building materials; consumer products and others.